Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
05/12/2010 | CN1899362B Quality control method for shenqi injection strengthening body resistance |
05/12/2010 | CN1895451B Medicinal composition for treating hives and eczema and its preparation |
05/12/2010 | CN1895266B Compound slow-releasing immune enhancer for cock |
05/12/2010 | CN1876822B Tacrolimus generation strain and production method thereof |
05/12/2010 | CN1867336B 1-aryl-4-substituted piperazines derivatives and pharmaceutical use thereof |
05/12/2010 | CN1803795B Substituted piperidine compounds for use as h3 histamine receptor antagonists |
05/12/2010 | CN1777575B Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
05/12/2010 | CN1738901B Modular antigen transporter molecules (MAT molecules) for modulating immune reactions, associated constructs, methods and uses |
05/12/2010 | CN1731979B Allergen dosage form |
05/12/2010 | CN1646558B Histone deacetylase inhibitors and process for producing the same |
05/12/2010 | CN1642552B 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
05/12/2010 | CN1636994B Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby |
05/12/2010 | CN1537000B Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists |
05/12/2010 | CN1466451B Ion-strength independent sustained release pharmacetuical formulation |
05/12/2010 | CN101705268A Wheat bran polysaccharide with antitumor and immune regulation activities and extraction method thereof |
05/12/2010 | CN101703781A Magnetic medicament loading method for immunosuppressant |
05/12/2010 | CN101703772A Compound indigowoad root oral liquid for improving poultry immunity and preparation method thereof |
05/12/2010 | CN101703771A Oil-in-water type compound vaccine adjuvant and method for preparing same |
05/12/2010 | CN101703744A Chinese medicinal composition for treating palpitation and shortness of breath and preparation method thereof |
05/12/2010 | CN101703618A Health care tea containing rehmanniae praeparatum and chrysanthemum |
05/12/2010 | CN101703567A Preparation method for traditional Chinese medicine composition for improving immunity of livestock and poultry and use thereof |
05/12/2010 | CN101703563A Eucommia donkey-hide glue potion for strengthening heart and bones |
05/12/2010 | CN101703547A Wormwood paste |
05/12/2010 | CN101703546A Sanchi extract pellets and preparation method thereof |
05/12/2010 | CN101703545A Ginkgo American ginseng saponin capsule and preparation method thereof |
05/12/2010 | CN101703539A Method for extracting okra by using supercritical carbon dioxide |
05/12/2010 | CN101703537A Ephedra total polysaccharide extractive and preparation method and medical application thereof |
05/12/2010 | CN101703532A Ganoderan polysaccharide pellet and preparation method thereof |
05/12/2010 | CN101703530A Mixed fungus ultrafine powder and preparation method thereof |
05/12/2010 | CN101703529A Cordyceps mycelia polysaccharide pellet and preparation method thereof |
05/12/2010 | CN101703518A Pharmaceutical composition of dsRNA and astragalus polysaccharide and application thereof |
05/12/2010 | CN101703493A Electrospinning composite nanofiber membrane of medicament ferulic acid, preparation method and application thereof |
05/12/2010 | CN101703491A Vitamin a powder and preparation method thereof |
05/12/2010 | CN101703487A Codonopsis pilosula polysaccharide pill |
05/12/2010 | CN101703484A Preparation method of hexadecadrol sodium phosphate freeze-dried powder injection |
05/12/2010 | CN101703477A Coenzyme Q10 mini-pill and preparation method thereof |
05/12/2010 | CN101703228A Health-care composition for strengthening immunity and preparation method thereof |
05/12/2010 | CN101143155B Double ginseng composition and its application |
05/12/2010 | CN101139558B Lactobacillus acidophilus and its application for improvement of blood lipid metabolism and immunological regulation |
05/12/2010 | CN101134108B Desonide cyclodextrin clathrate compound and method for preparing the same |
05/12/2010 | CN101112535B Medicinal composition and food and drink extender for improving immunity |
05/12/2010 | CN101112402B Medicinal composition and food and drink extender for improving immunity |
05/12/2010 | CN101068798B Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine |
05/12/2010 | CN101015379B Process for preparing agaricus blazei healht-care liquid |
05/12/2010 | CN101011421B Pollen tablet and its preparing process |
05/11/2010 | US7714120 Humanized anti-IL-1 beta antibodies |
05/11/2010 | US7714118 recombinant vectors encoding the FK-520 polyketide synthase and FK-520 modification enzymes can be used to produce the FK-520 polyketide; for immunosuppression or to stimulate nerve growth and regeneration |
05/11/2010 | US7714108 Mammalian tumor susceptibility gene products and their uses |
05/11/2010 | US7713992 adenosine receptor antagonists such as 2-(4-Methoxyphenyl)-9-benzylamino-10-cyano-s-triazolo[1,5-a]quinolin, used for treating respiratory system disorders, vision disorders, tumors, allergies or inflammatory disease, ischemia, hypoxia, arrhythmia or urogential disorders |
05/11/2010 | US7713972 Imidazotriazinone derivatives as PDE 7 (phosphodiesterase 7) inhibitors |
05/11/2010 | US7713529 Methods for treating and preventing infectious disease |
05/11/2010 | CA2455134C Adjuvants for use in vaccines |
05/11/2010 | CA2434670C Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
05/11/2010 | CA2422299C Triazole compounds useful as protein kinase inhibitors |
05/11/2010 | CA2326401C Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
05/06/2010 | WO2010050913A1 Vaccination with poxvirus vectors via mechanical epidermal disruption |
05/06/2010 | WO2010050584A1 Method for selectively controlling function of helper t cell |
05/06/2010 | WO2010050461A1 Novel amide derivative and use thereof as medicine |
05/06/2010 | WO2010050422A1 Agent for treatment of diabetes |
05/06/2010 | WO2010050178A1 Trehalose compound, method for producing same, and pharmaceutical product containing the compound |
05/06/2010 | WO2010050167A1 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same |
05/06/2010 | WO2010049921A1 Disaccharides |
05/06/2010 | WO2010049841A1 7-azaspiro [3.5] nonane-7-carboxamide compounds as modulators of fatty acid amide hydrolase |
05/06/2010 | WO2010049451A2 C-glycosidic analogues of alpha-galactosylceramids having immunostimulating and immunoregulating properties |
05/06/2010 | WO2010049438A2 Improved methods of using phosphoantigens for the treatment of diseases |
05/06/2010 | WO2010049144A2 Methods of identification of novel ligands for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (nr1f3) activity |
05/06/2010 | WO2010048731A1 Aminoacyl trna-synthetase inhibitors as broad-spectrum immunosuppressive agents |
05/06/2010 | WO2010011581A3 Polysaccharides extract from dendrobium for treating allergic diseases |
05/06/2010 | WO2010009129A3 Methods of treating autoimmune diseases using cd4 antibodies |
05/06/2010 | WO2010006326A3 Methods and compositions for spore-based vaccines |
05/06/2010 | WO2010002895A3 Lysosomal phospholipase a2 (lpla2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis |
05/06/2010 | WO2009158284A9 Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance |
05/06/2010 | WO2009158031A3 Methods and compositions for therapeutic treatment |
05/06/2010 | WO2009095719A3 Use of crac inhibitors and cysteinyl leukotriene inhibitors for treating allergy and asthma |
05/06/2010 | US20100113820 asthma, allergic conditions such as rhinitis, inflammatory bowel disease such as ulcerative colitis and Crohn's disease, rheumatoid arthritis, atopic dermatitis, multiple sclerosis; condensing N-(2,6-Difluorobenzoyl)-4-(2,6-dimethoxy-4-formal methylphenyl)-L-phenylalanine ethyl ester with ethanol |
05/06/2010 | US20100113796 Indole derivatives as s1p1 receptor |
05/06/2010 | US20100113770 O-substituted hydroxyaryl derivatives |
05/06/2010 | US20100113742 Modified polypeptides stabilized in a desired conformation and methods for producing same |
05/06/2010 | US20100113610 Methods for controlling inflammatory and immunological diseases |
05/06/2010 | US20100113608 Tryptase Enzyme Inhibiting Aminothiophenols |
05/06/2010 | US20100113599 Amphipathic carboxylates for the treatment of immune-related disorders |
05/06/2010 | US20100113597 Pharmaceutical composition for prevention of progress of intestinal constriction associated with crohn's disease |
05/06/2010 | US20100113542 Triazole derivative as an hsp 90 inhibitor |
05/06/2010 | US20100113538 N-hydroxy-4- benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same |
05/06/2010 | US20100113531 Thiazolidine derivatives as orexin receptor antagonists |
05/06/2010 | US20100113528 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists |
05/06/2010 | US20100113523 Tryptase Enzyme Inhibiting Aminopyridines |
05/06/2010 | US20100113518 Methods of using anti-inflammatory compounds |
05/06/2010 | US20100113503 Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors |
05/06/2010 | US20100113489 Modulators of chemokine receptor activity, crystalline forms and process |
05/06/2010 | US20100113471 2-Aminoaryloxazole compounds as tyrosine kinase inhibitors |
05/06/2010 | US20100113447 Triazole compounds that modulate hsp90 activity |
05/06/2010 | US20100113434 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
05/06/2010 | US20100113428 Diazabicyclic aryl derivatives as cholinergic receptor modulators |
05/06/2010 | US20100113389 Method of treating graft-rejection using dextran sulfate |
05/06/2010 | US20100113388 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
05/06/2010 | US20100113362 using polypeptides that can bind specifically to the CH2-CH3 cleft of an immunoglobulin molecule to inhibit Fc-mediated immune complex formation; rheumatoid arthritis |
05/06/2010 | US20100113361 Anti-ige vaccines |
05/06/2010 | US20100113332 Method of treating an inflammatory disease by double stranded ribonucleic acid |
05/06/2010 | US20100113331 Substituted Imidazole Derivatives, Compositions, and Methods of Use as PtPase Inhibitors |